Showing results (71-80 of 648) with videos related to
Sort By:
Pageof 65
Clinical and Experimental Pharmacology & Physiology|August 24, 2007
Role of macrophages in complications of type 2 diabetesG H TeschClinical Science (London, England : 1979)|August 2, 2017
Diabetic nephropathy - is this an immune disorder?Greg H TeschNephrology (Carlton, Vic.)|October 2, 2010
Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspectiveGreg H TeschCytokines and Molecular Therapy|September 1, 1996
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell linesA Klimka, S Barth, S Drillich, et al.Annals of Hematology|October 20, 1999
Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AMLH T Steinmetz, A Schulz, P Staib, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSGU Rueffer, M Sieber, A Josting, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study GroupV Diehl, M Sieber, U Rüffer, et al.Onkologie|December 1, 1981
Report on various clinical studies on high dose methotrexate in Europe (non EORTC)V DiehlEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Future strategy for cancer treatment using recombinant human granulocyte colony stimulating factorV DiehlPageof 65